Navigation Links
DePuy Recalled Hip Device Lawsuit Filed in Austin, Texas
Date:3/24/2011

AUSTIN, Texas, March 24, 2011 /PRNewswire/ -- Thomas Huxtable and his wife, Danielle, filed suit today against Johnson & Johnson, Inc. and DePuy Orthopaedics, Inc. seeking compensation for injuries caused by the failure of Mr. Huxtable's DePuy ASR XL Acetabular Hip Replacement System that has been recalled.  John David Hart of the Law Offices of John David Hart in Fort Worth, Texas, is the attorney representing Mr. and Mrs. Huxtable in the lawsuit filed in the United States District Court for the Western District of Texas in Austin, Texas.

"Thomas Huxtable is an active family man in his early 50s. He had the DePuy ASR XL Acetabular Hip Replacement System implanted in his right hip in October, 2008.  The device failed, leading to a revision surgery in less than two years.  This is unacceptable," said Mr. Hart.  "The device was not safe.  It was not effective.  Tom and Danielle should be fairly compensated for their injuries and losses caused by this failed, recalled device."

DePuy Orthopaedics, Inc., a division of Johnson and Johnson, Inc., recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. This recall came after data from a recent study indicated that the five year failure rate of this product is approximately 13%, or more than 1 out of every 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR XL Acetabular Hip Replacement System may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage.  This device was marketed by DePuy Orthopaedics as a high performance hip replacement system.

John David Hart and the Law Offices of John David Hart represent many individuals in the United States who have been injured as a result of this defective hip replacement system.  The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others.  Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs, automobile and truck accidents and oil and gas litigation.  For more information, please contact John David Hart at 800.961.4278 or johnhart@hartlaw.com.


'/>"/>
SOURCE The Law Offices of John David Hart
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DePuy Recalled Hip Device Lawsuit Filed in San Antonio, Texas
2. DePuy Recalled Hip Device Lawsuit Filed in East Texas
3. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
4. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
5. Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall
6. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
7. Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.
8. Chesley Files Class Action Against DePuy Orthopaedics
9. Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits
10. DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients
11. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):